Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma GlobeNewswire Sep 10, 2024 11:30am
Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences GlobeNewswire Sep 4, 2024 8:30pm
Jasper Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Developments GlobeNewswire Aug 13, 2024 11:00am